MIT, ImClone Battle in Court over Cancer Drug Patent

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/1924179/1924180" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Officials at the Massachusetts Institute of Technology are suing ImClone, the makers of a promising new cancer drug called Erbitux. The university says the drug is manufactured using technology patented by the school 20 years ago. Fights between universities and companies that use their research are becoming much more common. NPR's Snigdha Prakash reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.